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INTRODUCTION
Since its original description by Lennert in 1964, a variety
of names were used for this neoplasm before the recent gen-
eral acceptance of the term mantle cell lymphoma (MCL) (1).
MCL is a neoplastic lymphoid proliferation related to the
naive pregerminal center cells localized in the primary folli-
cle and to the mature mantle zone of the secondary lymphoid
follicles. MCL is a CD5 positive monoclonal B-cell malig-
nancy and is strongly associated with the t(11;14)(q13;q32)
translocation, which results in a rearrangement of the bcl-1
locus and overexpression of PRAD1/cyclin D1 mRNA tran-
script and protein (2). At the time of diagnosis of MCL, this
neoplasm frequently involves the bone marrow (BM) and
peripheral blood (PB) (3).
A variant of MCL has been described. The blastoid vari-
ant (B-MCL) exhibits histologic transformation to a higher
grade malignant lymphoma (4). This B-MCL exhibits a more
aggressive clinical course than typical MCL. B-MCL can be
problematic to diagnose correctly using morphologic exam-
ination alone. The neoplastic cells of B-MCL show larger and
more pleomorphic nuclei with finely dispersed chromatin
and increased mitotic figures. The cytomorphology of con-
ventional MCL by fine needle aspiration (FNA) cytology and
PB has been described (5). However, the published literature
describing the cytomorphologic feature of B-MCL diagnosed
based on the lymph node (LN) FNA cytology is limited to
only one case (6), and also the descriptions of morphological
features of PB of B-MCL are very rare. We report a case of
B-MCL diagnosed on the basis of cytomorphology and flow
cytometric analysis of immunophenotype of a LN FNA cyto-
logy and PB in a 62-yr-old man with generalized lymphade-
nopathy and PB involvement. Surgical LN biopsy confirmed
the diagnosis. The diagnosis was substantiated by the demon-
stration of bcl-1 gene rearrangement in circulating mantle
cell leukemic cells. 
MATERIALS AND METHODS
Case
The patient was a previously healthy 62-yr-old man who
had a 2-month history of epigastric fullness and generalized
lymphadenopathy, most pronounced in both inguinal areas.
Laboratory findings included the followings (reference ranges
given in parentheses): hemoglobin level of 9.3 g/dL (14.0-
18.0 g/dL) with normal red blood cell indices; normal platelet
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Mantle cell lymphoma, blastoid variant (B-MCL), is a very rare type of non-Hodgkin's
lymphoma exhibiting an aggressive clinical course. We describe a case of B-MCL
showing generalized lymphadenopathy and leukemic conversion in a 62-yr-old
man. The case was diagnosed and subclassified as B-MCL on the basis of cyto-
morphology and immunophenotype. Microscopic examination of the peripheral
blood (PB) showed a spectrum of cells ranging from small mature lymphocytes to
medium- and large-sized lymphocytes with blast-like chromatin and prominent nucle-
oli. The lymphoma cells were monoclonal B cells with moderately intense surface
IgM. They were CD5 positive, cyclin D1 positive, CD10 negative, and CD23 nega-
tive. The flow cytometric immunophenotyping and DNA ploidy analysis of the PB
and material obtained by aspiration cytology supported the diagnosis of B-MCL.
These findings underline the utility of aspiration cytology in diagnosing B-MCL
when cytomorphologic examination is combined with flow cytometric analysis of
immuno-phenotype and demonstration of proliferation markers. 
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count of 125×109/ L (130-400×109/ L); and a white blood
cell count of 18.5×109/ L (4.8-10.8×109/ L) with an abso-
lute lymphocytosis of 14.0×109/ L (0.9-2.9×109/ L). Sev-
enty percent of the PB lymphocytes were designated  “atyp-
ical lymphocytes or lymphoblast-like". Leukemic conversion
was found in PB. The reticulocyte differential was 1.7% (0.49-
1.87%). A whole body computerized axial tomography (CT)
scan showed a markedly aggregated lymphadenopathy in
retroperitoneum, celiac, peripancreatic, and portohepatic areas,
and hepatosplenomegaly. Subsequent physical examination
confirmed the hepatosplenomegaly. A FNA cytology of a 2.8
cm sized left inguinal LN was performed using a 23-gauge
needle. Three separate aspirations were performed and the
needle was rinsed in RPMI 1640 lymphoid culture medium
in order to perform analysis of flow cytometric immunophe-
notyping and gene rearrangement studies. Air-dried and
ethanol-fixed slides were made and stained using the Diff-
Quick and Papanicolaou methods, respectively. A BM aspirate
was obtained for cytogenetics in a sterile RPMI medium. A
BM core biopsy was performed, and diffuse infiltration of
malignant lymphoid cells was confirmed. Surgical LN biopsy
confirmed the diagnosis. The Ann Arbor stage of the patient
was determined as stage IV. The disease progressed very rapid-
ly, and patient did not agree to receive a course of chemother-
apy. He died 1 month after admission because of pleural effu-
sion, ascites, and cardiac arrest. Autopsy was not performed.
Cyto- and histomorphological evaluation
Air-dried smears of the PB, BM aspirate, LN touch print,
and LN aspirates were stained with Wright, Diff-Quik, or
Papanicoloau. B5-fixed, paraffin-embedded, 5- m sections
of the LN, BM core biopsy were stained with hematoxylin-
eosin and periodic acid-Schiff. For ultrastructural observation,
PB mononuclear cells were separated by Ficoll-Hypaque den-
sity gradient centrifugation. The pellet was washed in Hanks
solution, fixed overnight at 4℃with phosphate-buffered 3%
glutaraldehyde, post-fixed in 1% OsO4 in phosphate buffer
for 1 hr at 4℃, dehydrated in graded ethanol, and embed-
ded in epoxy resin. Ultrathin sections were stained with uranyl
acetate and lead citrate and then examined under a JEM 2000
FXII electron microscope. 
Immunophenotyping
Immunophenotyping of LN aspirate and PB was analyzed
by 2-color flow cytometry on a FACSCalibur flow cytometer
(Becton Dickinson, Mountain View, CA, U.S.A.) for various
antigens. The following commercially available monoclonal
antibodies were used: CD4, CD5, CD8, CD10, and HLA-
DR (Immune Source, Los Altos, CA, U.S.A.); CD3, CD7,
CD16+56, CD19, CD20, CD21, CD22, CD23, Ig , and
Ig (Becton Dickinson Immunocytochemistry Systems, San
Jose, CA, U.S.A.); IgM, IgD, IgG, IgA, and IgE (Pharmin-
gen, San Diego, CA. U.S.A.). Dual staining was performed as
follows: CD3/CD4, CD3/CD8, CD3/CD19, CD3/CD16+
56, CD3/HLA-DR, CD5/HLA-DR, CD5/CD19, CD7/
CD22, CD10/CD23, CD20/CD21, and Ig /Ig .
Also cyclin D1 (Santa-Cruz, CA, U.S.A.; R-124, 1:100)
in LN biospy was evaluated by immunohistochemistry.
DNA index and parameters, bcl-I/JH junction and cyto-
genetic analysis
For DNA analysis, 106 cells of FNA cytology were washed
twice with phosphate-buffered saline solution and fixed in
100% ethanol for 30 min at 4℃. After treatment with RNase
for 40 min at 37℃ the cells were stained with propidium
iodide (50 mg/mL). Cell cycle analysis and DNA index were
determined by FACSCalibur using calf thymocyte nuclei and
chicken erythrocyte nuclei as controls. 
DNA was extracted from LN aspirate by a standard phe-
nol-chloroform ethanol precipitation technique. Polymerase
chain reaction (PCR) analysis of the translocation involving
the major translocation cluster of the bcl-1 gene and the Ig
heavy chain gene was performed using both primer pairs, mcl-
1/JH and mcl-2/JH as previously described (7). The BM aspi-
rate was analyzed for cytogenetic abnormalities by the trypsin-
Giemsa banding method as previously described. 
RESULTS
Cytomorphology of B-MCL by light microscope
LN FNA smears
The Diff-Quik and Papanicolaou-stained smears revealed a
relatively uniform population of medium to large lymphoid
cells. The nuclei were approximately three to four times larg-
er than a mature, small lymphocytes nuclei. The nuclei had
slightly irregular outlines and fine, evenly dispersed chro-
matin, and the nuclei were cleaved in some cells. Most of
the nuclei contained 1 to 2 small nucleoli. The cytoplasm
was scant and stained pale blue on the Diff-Quik stained
smears. Mitoses were infrequently observed. 
PB smears
The lymphocytes had a fairly pleomorphic appearance and
consisted of a mixture of small, medium, and large cells. The
cells had slightly irregular nuclear outlines and ranged from
small lymphocytes with moderately coarse chromatin to medi-
um-sized lymphocytes with blast-like fine chromatin. The
predominant cells were medium-sized blast-like cells with
visible amounts of cytoplasm, round nuclei, relatively fine
chromatin and 1 to 2 prominent nucleoli. Some cells showed
nuclear irregularities, and others showed cleaved nuclei (Fig.
1). The smaller atypical lymphocytes were reminiscent of
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BM aspiration and biopsy
The BM aspirate showed a markedly hypercellular marrow
with decreased megakaryocytes. The normal hematopoietic
cells were almost totally replaced by malignant lymphoid
cells. Prussian blue staining showed slightly decreased stor-
age of iron. Most significantly, the BM aspirate showed an
increase in the number of small to medium and large-sized,
slightly irregular lymphocytes. The infiltrative lymphoma
cells were similar to those described in the PB, with numer-
ous blast-like cells. The BM core and clot sections showed
30% cellularity with myeloid, erythroid, and megakaryocytic
findings similar to those of the BM aspirate. The pattern of
BM involvement was diffusely infiltrative. The lymphoid
cells were small- to medium-sized and occasionally blast-like
in the BM core biopsy.
LN biopsy
The LN was diffusely replaced by lymphoma cells with
high mitotic rate (Fig. 2). The cells were small- to medium-
sized with slightly irregular nuclear outlines, moderately fine-
ly dispersed blast-like chromatin, and small or inconspicuous
nucleoli. No pseudofollicular proliferation centers, paraim-
munoblasts, or large lymphoid cells were present. Scattered
epithelioid histiocytes with granular eosinophilic cytoplasm
did not contain nuclear debris.
Ultrastructural features
The PB of the present B-MCL case showed pleomorphic
appearance and consisted of a mixture of small, medium and
large cells, and disclosed distinct ultrastructural features in-
cluding lymphoblast-like cells with a large and 1 to 2 promi-
nent nucleoli, high N/C ratio, and poorly developed cytoplas-
mic organelles, and cleaved or indented nucleus showing even
heterochromatin distribution, absent or inconspicuous nucle-
olus, low N/C ratio, abundant mitochondria, and a well devel-
oped endoplasmic reticulum.
Immunophenotyping 
Flow cytometric immunophenotypic analysis of the LN
aspirate and PB identified a monoclonal population of malig-
nant lymphoid B-cells with expression of CD19 (72%), CD20
(57%), CD22 (68%), IgM (55%),  light chain (51%), and
HLA-DR (70%), and aberrant expression of CD5 (76%),
while CD10 and CD23 elicited no reaction. The coexpres-
sion of CD5/CD19 and CD5/HLA-DR revealed 57.3% and
60.4% respectively.
The immunohistochemistry for cyclin D1 protein was
strong reactive in the nucleus of lymphoma cells in LN biop-
sy (Fig. 3) 
Proliferation markers
Flow cytometric DNA ploidy analysis demonstrated di-
ploid (31.6%) and aneuploid (68.4%) cell population with
a DNA index of 1.35 and an S+G2M fraction of 43.5%.
Fig. 1. Peripheral blood smear in leukemic mantle cell lymphoma,
blastoid variant. The cells range from small lymphocytes to medi-
um-sized blast-like cells with 1 to 2 nucleoli. Some cells show
cleaved nucleus (Wright stain,×1,000).
Fig. 2. Lymph node biopsy reveal the features of the pleomor-
phic malignant lymphoma cell showing medium and large cell
with prominent nucleoli (×400).176 M.-J. Lee, K.-H. Kee, H.-J. Jeon
Gene rearrangement studies and chromosome analysis
PCR analysis revealed a clonal rearrangement of the bcl-1/
Ig heavy chain fusion gene in DNA isolated from LN aspi-
rate (Fig. 4). Cytogenetic analyses of 20 metaphases prepared
from BM aspirates showed hypodiploid 44,X,-Y, and shared
the following cytogenetic abnormalities: add(1)(q43),add(4)
(q35),der(6)t(6;?)(q22;?),-9,-11,-13,-14,-15,+5mar[16]/46,
XY[4].
DISCUSSION
MCL, formerly known as intermediately differentiated lym-
phocytic lymphoma (Rappaport classification), centrocytic
lymphoma (Kiel classification), or mantle zone lymphoma,
is now accepted as a distinct clinicopathologic entity of non-
Hodgkin's lymphoma. The term MCL has become widely
accepted and is used in the Revised European-American Clas-
sification of Lymphoid Neoplasm, first published in 1994
(8). MCL is generally recognized to represent about 2.5 to
5% of all non-Hodgkin's lymphoma in the U.S.A. and 1.5%
in Korea (9). 
Since its original description of B-MCL by Lardelli et al.
(4), only few cases have been described in the literature. This
B-MCL have been referred to by a number of names such as
blastic, blastoid, large cell, lymphoblastoid, and pleomorphic.
Histologic transformation has been reported in up to 17%
of serially biopsied cases of MCL. B-MCL displays a distinct-
ly more aggressive clinical course (4).
While B-MCLs are uncommon lymphoid malignancies,
this neoplasm is associated with some distinct cytomorpho-
logic and immunophenotypic features (4). Conventional nodal
MCL is characterized by a homogeneous population of small-
to medium-sized lymphoid cells with scant pale cytoplasm,
indented nuclei, dispersed chromatin, and inconspicuous
nucleoli. Paraimmunoblasts and transformed cells are absent
from conventional MCL, resulting in monotonous features.
Cells of B-MCL exhibit a slightly larger size, from 1.5 to 3
times, blast-like morphologic features with more irregular
nuclei, a more dispersed chromatic pattern, higher mitotic
activity and more prominent nucleoli than those of conven-
tional MCL (8). Furthermore, cells of B-MCL can be much
less monotonous than those of common MCL, and thus may
frequently be confused with lymphoblastic lymphoma or
large cell lymphomas (4). The patient's clinical history can
be very helpful in making this distinction, because patients
with MCL are typically older adults, whereas patients with
lymphoblastic lymphoma are typically young and present
with mediastinal mass. 
The FNA cytology of typical cases of MCL has been de-
scribed (5), but the published literature describing the cyto-
morphologic features of B-MCL is limited to one case in
which a primary diagnosis of MCL had already been estab-
lished by surgical biopsy and the patients subsequently devel-
oped a pleural fluid or cerebrospinal fluid involvement, of
which the cytologic evaluation confirmed B-MCL (6). Hughes
et al. (6) demonstrated the first case of B-MCL diagnosed
based on the FNA cytology combined with ancillary studies. 
Immunophenotyping, cytogenetics, image analysis, and
Fig. 3. Immunohistochemistry stain for the cyclin D1 protein show
strong reactivity in the nucleus of lymphoma cell of lymph node
biopsy (×400).
600 bp
1 2
Fig. 4. Polymerase chain reaction analysis reveal a clonal rear-
rangement of the bcl-1/Ig heavy chain fusion gene in DNA iso-
lated from lymph node aspirate. Lane 1. Molecular marker,
Hae III-digested  ×174 RF DNA fragment. Lane 2. Extracted
DNA from lymph node aspirate.Blastoid Mantle Cell Lymphoma and Leukemia 177
molecular studies may be necessary to make a definitive diag-
nosis of MCL (6). Immunophenotypically, the conventional
type and B-MCL is characterized by co-expression of CD5
and CD20 antigens, and usually lacking CD10 and CD23.
The neoplastic cells have a monoclonal B-cell immunophe-
notype, almost always expressing surface IgM and IgD. The
monoclonal  light chain is expressed in about 60% of MCL.
The MCL can be differentiated from chronic lymphocytic
leukemia (CLL)/small lymphocytic lymphoma (SLL) by the
immunophenotypic marker, CD23 (10). Immunophenotypi-
cally, CLL expresses CD23 and weak intensity surface Ig and
CD20, while mantle cell leukemic cells lack CD23 and ex-
presses moderate to strong intensity surface Ig and CD20. If
morphologic examination is combined with immunopheno-
typic and molecular analysis, more cases of B-MCL will be
detected.
At the time of diagnosis, MCL frequently involves the PB
and BM (3, 11). Neoplastic lymphoid (mantle cell leukemic)
cells are found in PB smears of approximately one quarter to
one third of patients with MCL using morphologic examina-
tion alone. Large studies of MCL have found a high propor-
tion of cases with BM involvement from 53 to 93%. When
confronted with a PB containing the blast-like cells, the dif-
ferential diagnosis should include acute leukemia, prolym-
phocytic leukemia, and peripheralized large cell lymphoma.
In B-MCL with PB involvement, the circulating lymphoma
cells show slightly irregular nuclear contours, ranging from
small cells with moderately coarse chromatin to medium-
sized blast-like cells with finer blast-like chromatin than con-
ventional type of leukemic phase of MCL.
Cells of acute lymphoblastic leukemia lack surface Ig and
cyclin D1 expression, and express TdT; those of B-MCL ex-
press surface Ig, but not TdT. Large cell lymphoma cells rarely
coexpress CD5. The leukemic cells of follicular center cell
(FCC) lymphoma, small cleaved type, are smaller with coarse
chromatin and nuclear cleft. The FCC lymphoma often ex-
presses CD10 but lacks CD5, and is associated with a t(14;18).
The PB smear in the mixed cell type of CLL shows less pleo-
morphism and rounded nuclei, however some cases of CLL
may have irregular nuclear contours, making the morpho-
logical distinction from MCL. 
It is difficult to diagnose patients with B-MCL correctly
without immunophenotyping, and molecular analysis can
substantiate the diagnosis. MCL is distinguished by a char-
acteristic chromosmal translocation. A chromosomal translo-
cation t(11;14) involving the Ig heavy chain gene locus
(14q32) and the bcl-1 locus (11q13) is seen in approximate-
ly 95% of MCL cases. This translocation has been detected
in both conventional MCL and B-MCL, and results in an
overexpression of the cyclin D1 protein, a cell-cycle protein
that is not normally expressed at high levels in lymphoid cells.
Bcl-1 gene rearrangement and/or the t(11;14) translocation
detected by either southern blot hybridization or PCR anal-
ysis, and tetraploid chromosomes may be more common in
B-MCL. Although our case did not exhibit the t(11;14)
translocation in cytogenetic analysis, it should be noted that
a bcl-1 rearrangement and overexpression of cyclin D1 were
present. While the t(11;14) seen in conventional MCL has
also been reported in B-MCL, the full spectrum of cytogenet-
ic abnormalities associated with B-MCL is not well-charac-
terized because of the rarity of the B-MCL. B-MCL shows a
higher proliferation rate, as shown by Ki-67 antigen expres-
sion, and has a higher incidence of p53 immunostaining than
the conventional MCL (6). 
The present case demonstrates that cytomorphology com-
bined with flow cytometric analysis of immunophenotype
and proliferation markers obtained by LN FNA cytology and
PB is helpful to confirm B-MCL, which can be further sub-
stantiated by the demonstration of bcl-1 gene rearrangement.
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